课题基金 / 基金详情

Next Generation Antibody Therapeutics

Next Generation Antibody Therapeutics
下一代抗体疗法
批准号:
nhmrc : GNT1157744
负责人:
A/Pr Daniel Christ
金额:
$71.73万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Research Fellowships
财政年份:
2019
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2019-01-01 至 --

项目摘要

项目成果

A/Pr Daniel Christ的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This research will focus on an important problem, namely the limitations on specificity and persistence of human antibodies. Although often perceived as a perfect 'lock-and-key' phenomenon, many antibodies in fact display limited specificity and interact with unrelated targets resulting in short persistence and off-target effects. By deciphering mutational and structural mechanisms unpinning antibody specificity, my research will advance the development of next generation antibody therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathological and therapeutic antibody production
  • 批准号:
    nhmrc : 1113904
  • 项目类别:
    Program Grants
  • 资助金额:
    $627.93万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Daniel Christ
  • 依托单位:
Pathological and therapeutic antibody production
  • 批准号:
    nhmrc : GNT1113904
  • 项目类别:
    Programs
  • 资助金额:
    $918.42万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Daniel Christ
  • 依托单位:
Positive and negative selection in the germinal centre reaction
  • 批准号:
    nhmrc : GNT1105875
  • 项目类别:
    Project Grants
  • 资助金额:
    $129.0万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Daniel Christ
  • 依托单位:
Development of stable human antibody phage display libraries
  • 批准号:
    nhmrc : GNT1113790
  • 项目类别:
    Development Grants
  • 资助金额:
    $53.96万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Daniel Christ
  • 依托单位:
国内基金
海外基金
Next Generation Majorana Nanowire Hybrids